These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 9568121

  • 1. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids.
    Samadder P, Byun HS, Bittman R, Arthur G.
    Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial cancer cell growth.
    Erukulla RK, Zhou X, Samadder P, Arthur G, Bittman R.
    J Med Chem; 1996 Mar 29; 39(7):1545-8. PubMed ID: 8691486
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
    Salari H, Dryden P, Davenport R, Howard S, Jones K, Bittman R.
    Biochim Biophys Acta; 1992 Feb 19; 1134(1):81-8. PubMed ID: 1543759
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR, Bittman R, Peters A, Mayhew E.
    J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506
    [Abstract] [Full Text] [Related]

  • 6. An active endocytosis pathway is required for the cytotoxic effects of glycosylated antitumor ether lipids.
    Samadder P, Byun HS, Bittman R, Arthur G.
    Anticancer Res; 2011 Nov 16; 31(11):3809-18. PubMed ID: 22110203
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 8. Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
    Bittman R, Byun HS, Reddy KC, Samadder P, Arthur G.
    J Med Chem; 1997 Apr 25; 40(9):1391-5. PubMed ID: 9135036
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 10. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P, Richards C, Bittman R, Bhullar RP, Arthur G.
    Anticancer Res; 2003 Aug 01; 23(3B):2291-5. PubMed ID: 12894505
    [Abstract] [Full Text] [Related]

  • 11. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 12. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
    Zhou X, Lu X, Richard C, Xiong W, Litchfield DW, Bittman R, Arthur G.
    J Clin Invest; 1996 Aug 15; 98(4):937-44. PubMed ID: 8770865
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.
    Ashagbley A, Samadder P, Bittman R, Erukulla RK, Byun HS, Arthur G.
    Anticancer Res; 1996 Aug 15; 16(4A):1813-8. PubMed ID: 8712705
    [Abstract] [Full Text] [Related]

  • 14. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
    Samadder P, Xu Y, Schweizer F, Arthur G.
    Eur J Med Chem; 2014 May 06; 78():225-35. PubMed ID: 24681987
    [Abstract] [Full Text] [Related]

  • 16. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P, Arthur G.
    Cancer Res; 1999 Oct 01; 59(19):4808-15. PubMed ID: 10519389
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antitumor activity of ether glycerophospholipids bearing a carbamate moiety at the sn-2 position: selective sensitivity against prostate cancer cell lines.
    Byun HS, Bittman R, Samadder P, Arthur G.
    ChemMedChem; 2010 Jul 05; 5(7):1045-52. PubMed ID: 20533503
    [Abstract] [Full Text] [Related]

  • 18. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A, Huleihel M, Segal S, Apte RN.
    Eur Cytokine Netw; 1991 Jul 05; 2(4):257-64. PubMed ID: 1756231
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb 05; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 20. Glycosylated antitumor ether lipids: activity and mechanism of action.
    Arthur G, Bittman R.
    Anticancer Agents Med Chem; 2014 May 05; 14(4):592-606. PubMed ID: 24628233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.